Treating

AI-Driven Drug Discovery Achieves Milestone with Insilico Medicine’s Phase IIa Success in Treating Pulmonary Fibrosis

In a breakthrough for AI-powered drug discovery, Insilico Medicine announced positive Phase IIa results for its novel drug ISM001-055, designed to treat Idiopathic Pulmonary Fibrosis (IPF). This small molecule, developed using Insilico’s proprietary generative...

Recent posts

Popular categories

ASK DUKE